Sarah T Diepstraten

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 22

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

Cell death and differentiation

Nature reviews. Cancer

Biochemical Society transactions

This page only lists publications with an associated author ORCID identifier.

Publications

Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
Correction to: The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation 31 (2) (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation 31 (2) (2023)
Sarah T Diepstraten, Savannah Young, John E La Marca, Zilu Wang, Ruth M Kluck, Andreas Strasser, Gemma L Kelly
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs. Cell death and differentiation (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation 31 (2) (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation 31 (2) (2023)
Zilu Wang, Matteo Burigotto, Sabrina Ghetti, François Vaillant, Tao Tan, Bianca D Capaldo, Michelle Palmieri, Yumiko Hirokawa, Lin Tai, Daniel S Simpson, Catherine Chang, Allan Shuai Huang, Elizabeth Lieschke, Sarah T Diepstraten, Deeksha Kaloni, Chris Riffkin, David Ching Siang Huang, Connie Li Wai Suen, Alexandra L Garnham, Peter Gibbs, Jane E Visvader, Oliver M Sieber, Marco J Herold, Luca L Fava, Gemma L Kelly, Andreas Strasser
Loss-of-function but not gain-of-function properties of mutant TP53 are critical for the proliferation, survival and metastasis of a broad range of cancer cells. Cancer discovery (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation 31 (2) (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
John E La Marca, Brandon J Aubrey, Bruce Yang, Catherine Chang, Zilu Wang, Andrew Kueh, Lin Tai, Stephen Wilcox, Liz Milla, Susanne Heinzel, David Vremec, Lauren Whelan, Christina König, Deeksha Kaloni, Anne Kathrin Voss, Andreas Strasser, Sarah T Diepstraten, Marco J Herold, Gemma L Kelly
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses. Cell death and differentiation 31 (2) (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Zilu Wang, Huimin Hu, Luuk Heitink, Kelly L Rogers, Yue You, Tao Tan, Connie Li Wai Suen, Alex Garnham, Hao Chen, Elizabeth Lieschke, Sarah T Diepstraten, Catherine Chang, Tianwei Chen, Diane Moujalled, Kate D Sutherland, Guillaume L Lessene, Oliver M Sieber, Jane Visvader, Gemma L Kelly, Andreas Strasser
The anti-cancer agent APR-246 can activate several programmed cell death processes to kill malignant cells. Cell death and differentiation (2023)
Sarah T Diepstraten, John E La Marca, Catherine Chang, Savannah Young, Andreas Strasser, Gemma L Kelly
BCL-W makes only minor contributions to MYC-driven lymphoma development. Oncogene (2023)
Sarah T Diepstraten, Savannah Young, John E La Marca, Zilu Wang, Ruth M Kluck, Andreas Strasser, Gemma L Kelly
Lymphoma cells lacking pro-apoptotic BAX are highly resistant to BH3-mimetics targeting pro-survival MCL-1 but retain sensitivity to conventional DNA-damaging drugs. Cell death and differentiation (2023)
Brandon J Aubrey, Margs S Brennan, Sarah T Diepstraten, Zilu Wang, Catherine Chang, Marco J Herold, Andreas Strasser, Gemma L Kelly
Loss of TRP53 reduces but does not overcome dependency of lymphoma cells on MCL-1. Cell death and differentiation 29 (5) (2022)
Gaoyuan Wang, Sarah T Diepstraten, Marco J Herold
Last but not least: BFL-1 as an emerging target for anti-cancer therapies. Biochemical Society transactions 50 (4) (2022)
Rachel Thijssen, Sarah T Diepstraten, Donia Moujalled, Edward Chew, Christoffer Flensburg, Melissa X Shi, Michael A Dengler, Veronique Litalien, Sarah MacRaild, Maoshan Chen, Natasha S Anstee, Boris Reljić, Sarah S Gabriel, Tirta M Djajawi, Chris D Riffkin, Brandon J Aubrey, Catherine Chang, Lin Tai, Zhen Xu, Thomas Morley, Giovanna Pomilio, Claudia Bruedigam, Axel Kallies, David Arthur Stroud, Ashish Bajel, Ruth M Kluck, Steven W Lane, Marie Schoumacher, Sébastien Banquet, Ian J Majewski, Andreas Strasser, Andrew W Roberts, David Ching Siang Huang, Fiona C Brown, Gemma L Kelly, Andrew H Wei
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias. Blood 137 (20) (2021)
Sarah T Diepstraten, Mary Ann Anderson, Peter E Czabotar, Guillaume L Lessene, Andreas Strasser, Gemma L Kelly
The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs. Nature reviews. Cancer (2021)
Charis E Teh, Alissa K Robbins, Darren C Henstridge, Grant Dewson, Sarah T Diepstraten, Gemma Kelly, Mark A Febbraio, Sarah S Gabriel, Lorraine A O'Reilly, Andreas Strasser, Daniel H D Gray
MCL-1 is essential for survival but dispensable for metabolic fitness of FOXP3+ regulatory T cells. Cell death and differentiation 27 (12) (2020)